Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 882 across all filing types
Latest filing 2026-06-19 Share Issue/Capital Cha…
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - ADR 7 pages 21.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3G form, which is a regulatory announcement notifying the issue, conversion, or payment up of unquoted equity securities under an employee incentive scheme. It specifies details about new unquoted options issued, including security codes, number of securities, issue date, and recipients, including key management personnel. There are no financial statements or comprehensive financial analysis included. Instead, this is a formal notification of a securities issuance event under listing rules, specifically concerning share options. This fits the category of Share Issue/Capital Change announcements, since it involves new securities issuance and capital structure changes.
2026-06-19 English
Results of Extraordinary General Meeting 2 pages 307.0KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement regarding the results of an Extraordinary General Meeting (EGM) held on 19 June 2026. It contains detailed voting results on multiple resolutions that were subject to shareholder approval. The presence of proxy voting details, resolutions passed or not passed, and references to the Corporations Act 2001 and ASX Listing Rule 3.13.2 clearly indicate that this document is reporting the official voting results from a shareholder meeting. There is no financial performance data or company operational details typical of annual or interim reports. Nor is this a notice or solicitation to vote. Therefore, this fits precisely the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA). The document length and content align with a detailed announcement of voting outcomes rather than a brief note or mere report publication announcement.
2026-06-19 English
Adherium Investor Webinar Invitation 2 pages 171.3KB
Investor Presentation Classification · 90% confidence The document is an ASX release announcing and inviting investors to a webinar scheduled for June 25, 2026. It outlines the agenda of the webinar including corporate strategy, commercialization plans, and business updates but does not present financial statements, detailed financial performance, or any formal financial report. The content focuses on an upcoming presentation event rather than containing financial results or management discussion. The document length of approximately 3,096 characters is relatively short, and the document is mainly an invitation and overview of the webinar topics. Hence, it classifies as an Investor Presentation announcement (IP) rather than an actual comprehensive financial or annual report or earnings release.
2026-06-18 English
Postponement of Investor Webinar 1 page 108.9KB
Regulatory Filings Classification · 90% confidence The document is an ASX market release announcing the postponement of an investor webinar. It does not contain financial statements or investor presentation materials, nor does it discuss management changes, dividends, capital events, or regulatory filings beyond this notice. It is a routine market announcement and does not fit any specific category such as earnings release, presentation, or financial report. Therefore it falls under the fallback category for general regulatory announcements: RNS.
2026-06-10 English
Initial Director's Interest Notice - Victoria Durrans 2 pages 169.2KB
Director's Dealing Classification · 96% confidence The document is an ASX Appendix 3X “Initial Director’s Interest Notice” under Listing Rule 3.19A.1, disclosing a director’s securities interests (nil in this case). This is a personal share transaction/holding disclosure by a company director, which fits the “Director’s Dealing” category.
2026-06-01 English
Final Director's Interest Notice - Bruce McHarrie 2 pages 184.2KB
Director's Dealing Classification · 88% confidence The document is an ASX Appendix 3Z “Final Director’s Interest Notice” disclosing a director’s relevant interests and changes in shareholdings under listing rule 3.19A.3. This falls squarely under insider share transactions by a director, matching the Director’s Dealing category.
2026-06-01 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.